BUY Cipla Ltd. — ICICI Securities

Entry₹1,532.5Inferred
Target₹1,800
Total upside +17.46% (call closed)
Stop lossNot given
At expiry₹1,410.624 Jul 2026, 3:30 pm
Expired-7.95%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Jul 2026
4 supporting11 neutral17 opposing
Supports the BUY call (4)

5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·24 Jul · today

Earning Estimates: Infosys, Cipla, IndiGo, Meesho, Mphasis & Allied Blenders Q1 Results Today — What To Expect

NewsNdtv-Profit·23 Jul · yesterday

(opens in new tab)

Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

NewsLivemint·20 Jul · 4d ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Jul · 2w ago

Weighs against the BUY call (17)

Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious

NewsHbl·24 Jul · today

(opens in new tab)

2 advisors have active short-term SELL calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·24 Jul · today

2 other SEBI-registered advisors have active long-term SELL calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·24 Jul · today

Cipla Q1 results: Profit falls 39% YoY to ₹789.05 crore

NewsLivemint·23 Jul · yesterday

(opens in new tab)

Cipla Q1 results: Profit falls 39% YoY to ₹789 crore; revenue climbs 3.50%

NewsLivemint·23 Jul · yesterday

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.